Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin and Prediction of Treatment Response in PHN
NCT01603394Phase 4Terminated
- Sponsor
- Pfizer
- Start
- Oct 2012
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 4 trial of pregabalin in postherpetic neuralgia (PHN), sponsored by Pfizer. Started Oct 2012; status: terminated.
02
Drugs
pregabalin
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT01603394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01603394.